Inflammatory Biomarkers and Comorbidities in Chronic Obstructive Pulmonary Disease

Mette Bastkjær Thomsen, Morten Dahl, Peter Lange, Jørgen Vestbo, Børge Nordestgaard

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstrakt

RATIONALE: Patients with chronic obstructive pulmonary disease (COPD) have evidence of systemic inflammation that may be implicated in the development of comorbidities. OBJECTIVES: To test the hypothesis that elevated levels of three inflammatory biomarkers are associated with increased risk of comorbidities in COPD. METHODS: We examined 8656 COPD patients from two large Danish population studies and during a median five years follow-up recorded hospital admissions due to major comorbidities as endpoints. MEASUREMENTS AND MAIN RESULTS: We measured baseline C-reactive protein (CRP), fibrinogen, and leukocyte count, and recorded admissions due to ischemic heart disease, myocardial infarction, heart failure, type II diabetes, lung cancer, pneumonia, pulmonary embolism, hip fracture, and depression for all participants. Multifactorially adjusted risk of ischemic heart disease was increased by a factor of 2.19(95%confidence interval:1.48-3.23) in individuals with three biomarkers elevated (CRP above 3 mg per liter, fibrinogen above 14 μmol per liter, and leukocyte count above 9 x109 per liter) versus individuals with all three biomarkers at or below these limits. Corresponding hazard ratios were 2.32(1.34-4.04) for myocardial infarction, 2.63(1.71-4.04) for heart failure, 3.54(2.03-6.19) for diabetes, 4.00(2.12-7.54) for lung cancer, and 2.71(2.03-3.63) for pneumonia. There were no consistent differences in risk of pulmonary embolism, hip fracture, or depression as a function of these three biomarkers. CONCLUSIONS: Simultaneously elevated levels of CRP, fibrinogen, and leukocyte count are associated with a 2 to 4-fold increased risk of major comorbidities in COPD. These biomarkers may be an additional tool for clinicians to conduct stratified management of comorbidities in COPD.
OriginalsprogEngelsk
TidsskriftAmerican Journal of Respiratory and Critical Care Medicine
Vol/bind186
Udgave nummer10
Sider (fra-til)982-8
Antal sider7
ISSN1073-449X
DOI
StatusUdgivet - 2012

Fingeraftryk Dyk ned i forskningsemnerne om 'Inflammatory Biomarkers and Comorbidities in Chronic Obstructive Pulmonary Disease'. Sammen danner de et unikt fingeraftryk.

Citationsformater